Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    February 2019
  1. GORGEN A, Rosales R, Sadler E, Beecroft R, et al
    Patterns and Predictors of Mortality after Waitlist Dropout of Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation.
    Transplantation. 2019 Feb 18. doi: 10.1097/TP.0000000000002616.
    PubMed     Text format     Abstract available


  2. RHU J, Kim JM, Choi GS, Hyuck C, et al
    The impact of extra-anatomical hepatic artery reconstruction during living donor liver transplantation on biliary complications and graft and patient survival.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002601.
    PubMed     Text format     Abstract available


  3. KOC C, Akbulut S, Ozdemir F, Kose A, et al
    Analysis of Risk Factors Affecting the Development of Infection in Artificial Vascular Grafts Used for Reconstruction of Middle Hepatic Vein Tributaries in Living Donor Liver Transplantation.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002583.
    PubMed     Text format     Abstract available


  4. CHEN K, Sheng J, Ma B, Cao W, et al
    Suppression of hepatocellular carcinoma by mycophenolic acid in experimental models and in patients.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002647.
    PubMed     Text format     Abstract available


    November 2018

  5. Analysis of Differentially Expressed Proteins in Hepatocellular Carcinoma: Erratum.
    Transplantation. 2018 Nov 12. doi: 10.1097/TP.0000000000002534.
    PubMed     Text format    


  6. PAUL S, Charlton M
    Liver Transplantation for Nonalcoholic Steatohepatitis: New Evidence of a Profound Increase Across Age Cohorts.
    Transplantation. 2018 Nov 5. doi: 10.1097/TP.0000000000002513.
    PubMed     Text format    


    October 2018
  7. YOUNOSSI ZM, Marchesini G, Pinto-Cortez H, Petta S, et al
    Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Transplantation. 2018 Oct 17. doi: 10.1097/TP.0000000000002484.
    PubMed     Text format     Abstract available


  8. RATZIU V, Ghabril M, Romero-Gomez M, Svegliati-Baroni G, et al
    Recommendations for management and treatment of nonalcoholic steatohepatitis.
    Transplantation. 2018 Oct 8. doi: 10.1097/TP.0000000000002483.
    PubMed     Text format     Abstract available


  9. LU WY, Forbes SJ
    Telomerase Activity Links to Regenerative Capacity of Hepatocytes.
    Transplantation. 2018;102:1587-1588.
    PubMed     Text format    


    August 2018
  10. TSOCHATZIS E, Coilly A, Nadalin S, Levistky J, et al
    International Liver Transplantation Consensus Statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation.
    Transplantation. 2018 Aug 27. doi: 10.1097/TP.0000000000002433.
    PubMed     Text format     Abstract available


    July 2018
  11. GADSDEN MM, Goldberg DS
    Hepatic Dysfunction in Deceased Donors in the Age of the Opioid Epidemic.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002368.
    PubMed     Text format    


  12. BARBIER L, Bucur P, Salame E
    Extended-criteria allografts a strategy to reduce waiting list mortality in selected hepatocellular carcinoma recipients.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002365.
    PubMed     Text format    


  13. HEITS N, Brosch M, Herrmann A, Behrens R, et al
    EVOLUTIONARY DISTANCE PREDICTS RECURRENCE AFTER LIVER TRANSPLANTATION IN MULTIFOCAL HEPATOCELLULAR CARCINOMA.
    Transplantation. 2018 Jul 9. doi: 10.1097/TP.0000000000002356.
    PubMed     Text format     Abstract available


  14. THULUVATH PJ, Hanish S, Savva Y
    Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared to Cryptogenic, Alcoholic or AIH Cirrhosis.
    Transplantation. 2018 Jul 5. doi: 10.1097/TP.0000000000002355.
    PubMed     Text format     Abstract available


  15. DOMEN J
    Minimally invasive transplantation of primary human hepatocyte inserts that facilitate vascularization.
    Transplantation. 2018 Jul 3. doi: 10.1097/TP.0000000000002331.
    PubMed     Text format    


  16. CROOME KP, Mathur AK, Lee DD, Moss AA, et al
    Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.
    Transplantation. 2018;102:1108-1114.
    PubMed     Text format     Abstract available


  17. LEE KW, Han S, Lee S, Cha HH, et al
    Higher Risk of Posttransplant Liver Graft Failure in Male Recipients of Female Donor Grafts Might Not Be Due to Anastomotic Size Disparity.
    Transplantation. 2018;102:1115-1123.
    PubMed     Text format     Abstract available


    June 2018
  18. SEALE N, Ramaswamy S, Shih YR, Verma I, et al
    Macroporous dual compartment hydrogels for minimally invasive transplantation of primary human hepatocytes.
    Transplantation. 2018 Jun 18. doi: 10.1097/TP.0000000000002330.
    PubMed     Text format     Abstract available


  19. MIYAAKI H, Miuma S, Taura N, Shibata H, et al
    Risk factors and clinical course for liver steatosis or nonalcoholic steatohepatitis after living donor liver transplantation.
    Transplantation. 2018 Jun 11. doi: 10.1097/TP.0000000000002319.
    PubMed     Text format     Abstract available


    May 2018
  20. LI F, Jiao A, Li X, Zhang C, et al
    Survival and Metabolic Function of Syngeneic Mouse Islet Grafts Transplanted into the Hepatic Sinus-tract.
    Transplantation. 2018 May 22. doi: 10.1097/TP.0000000000002289.
    PubMed     Text format     Abstract available


  21. RODRIGUEZ-PERALVAREZ M, Guerrero M, Barrera L, Ferrin G, et al
    Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation.
    Transplantation. 2018 May 11. doi: 10.1097/TP.0000000000002270.
    PubMed     Text format     Abstract available


  22. PARKER A, Karvellas CJ
    Coagulation Defects in the Cirrhotic Patient Undergoing Liver Transplantation.
    Transplantation. 2018 May 7. doi: 10.1097/TP.0000000000002273.
    PubMed     Text format     Abstract available


  23. MARCON F, Schlegel A, Bartlett DC, Kalisvaart M, et al
    Utilization of Declined Liver Grafts Yields Comparable Transplant Outcomes and Previous Decline Should Not Be a Deterrent to Graft Use.
    Transplantation. 2018;102:e211-e218.
    PubMed     Text format     Abstract available


    April 2018
  24. HOGEN R, Lo M, DiNorcia J, Ji L, et al
    More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma.
    Transplantation. 2018 Apr 18. doi: 10.1097/TP.0000000000002248.
    PubMed     Text format     Abstract available


  25. SPENGLER EK
    The Author's Reply.
    Transplantation. 2018;102:e189-e190.
    PubMed     Text format    


    March 2018
  26. VANWAGNER LB, Montag S, Zhao L, Allen NB, et al
    Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment Following Liver Transplantation.
    Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002175.
    PubMed     Text format     Abstract available


    February 2018
  27. KIM JM, Kwon CHD, Joh JW, Han S, et al
    ABO-incompatible Living Donor Liver Transplantation with Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Transplantation. 2018 Feb 28. doi: 10.1097/TP.0000000000002154.
    PubMed     Text format     Abstract available


  28. CHARLTON M, Levitsky J, Aqel B, O'Grady J, et al
    International Liver Transplant Society Consensus Statement on IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002147.
    PubMed     Text format    


  29. RHU J, Kim JM, Choi GS, Kwon CHD, et al
    Validation of the alpha-fetoprotein model for hepatocellular carcinoma recurrence after transplantation in an Asian population.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002136.
    PubMed     Text format     Abstract available


  30. THULUVATH AJ, Chen PH, Thuluvath PJ, Kantsevoy S, et al
    Poor Survival after Retransplantation in NASH cirrhosis.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002135.
    PubMed     Text format     Abstract available


  31. ADELMANN D, Olmos A, Liu LL, Feiner JR, et al
    Intraoperative management of liver transplant patients without the routine use of renal replacement therapy.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002137.
    PubMed     Text format     Abstract available


  32. SAVALE L, Duclos-Vallee JC, Sitbon O
    Outcome of portopulmonary hypertension after liver transplantation: perhaps not so optimistic.
    Transplantation. 2018 Feb 2. doi: 10.1097/TP.0000000000002112.
    PubMed     Text format    


    January 2018
  33. QUARELLO P, Tandoi F, Carraro F, Vassallo E, et al
    Successful sequential liver and haematopoietic stem cell transplantation in a child with CD40 ligand deficiency and Cryptosporidium-induced liver cirrhosis.
    Transplantation. 2018 Jan 26. doi: 10.1097/TP.0000000000002114.
    PubMed     Text format     Abstract available


  34. GIARD JM, Mehta N, Dodge JL, Roberts JP, et al
    Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2018 Jan 17. doi: 10.1097/TP.0000000000002094.
    PubMed     Text format     Abstract available


  35. BEZINOVER D, Dirkmann D, Findlay J, Guta C, et al
    Perioperative Coagulation Management in Liver Transplant Recipients.
    Transplantation. 2018 Jan 15. doi: 10.1097/TP.0000000000002092.
    PubMed     Text format     Abstract available


  36. ECKER BL, Hoteit MA, Forde KA, Hsu CC, et al
    Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002056.
    PubMed     Text format     Abstract available


  37. SADLER EM, Mehta N, Bhat M, Ghanekar A, et al
    Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002043.
    PubMed     Text format     Abstract available


  38. YAO S, Yagi S, Uozumi R, Iida T, et al
    A high portal venous pressure gradient increases gut-related bacteremia and consequent early mortality after living donor liver transplantation.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002047.
    PubMed     Text format     Abstract available


  39. GIRETTI G, Barbier L, Bucur P, Marques F, et al
    Recipient Selection for Optimal Utilization of Discarded Grafts in Liver Transplantation.
    Transplantation. 2018 Jan 2. doi: 10.1097/TP.0000000000002069.
    PubMed     Text format     Abstract available


    December 2017
  40. IANNELLI A, Schiavo L
    Very low-calorie diet, the morbidly obese with liver cirrhosis and bariatric surgery.
    Transplantation. 2017 Dec 22. doi: 10.1097/TP.0000000000002065.
    PubMed     Text format    


  41. SPENGLER EK
    The Author's Reply: Very low-calorie diet, the morbidly obese with liver cirrhosis and bariatric surgery.
    Transplantation. 2017 Dec 22. doi: 10.1097/TP.0000000000002064.
    PubMed     Text format    


  42. THULUVATH PJ, Hanish S, Savva Y
    Liver Transplantation in Cryptogenic Cirrhosis: Outcome comparisons between NASH, Alcoholic and AIH cirrhosis.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002030.
    PubMed     Text format     Abstract available


    November 2017
  43. PUCHADES L, Chau S, Dodson JA, Mohamad Y, et al
    Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation (FrAILT) Study.
    Transplantation. 2017 Nov 20. doi: 10.1097/TP.0000000000002025.
    PubMed     Text format     Abstract available


  44. LI CX, Man K, Lo CM
    The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation.
    Transplantation. 2017;101:2665-2670.
    PubMed     Text format     Abstract available


  45. GREY ST, Issa F
    The 2017 Transplantation Awards: Recognizing a Landmark Clinical Trial and a Basic Science Discovery With Far-Reaching Implications.
    Transplantation. 2017;101:2655-2656.
    PubMed     Text format    


    October 2017
  46. REYMOND M, Barbier L, Salame E, Besh C, et al
    Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
    Transplantation. 2017 Oct 26. doi: 10.1097/TP.0000000000001981.
    PubMed     Text format     Abstract available


  47. ZHU J, Chen PY, Frankel M, Selby RR, et al
    Contemporary Policies Regarding Alcohol and Marijuana use Among Liver Transplant Programs in the United States.
    Transplantation. 2017 Oct 10. doi: 10.1097/TP.0000000000001969.
    PubMed     Text format     Abstract available


  48. SPENGLER EK, O'Leary JG, Te HS, Rogal S, et al
    Liver Transplantation in the Obese Cirrhotic Patient.
    Transplantation. 2017;101:2288-2296.
    PubMed     Text format     Abstract available


  49. WENG J, Li W, Jia X, An W, et al
    Alleviation of Ischemia-Reperfusion Injury in Liver Steatosis by Augmenter of Liver Regeneration Is Attributed to Antioxidation and Preservation of Mitochondria.
    Transplantation. 2017;101:2340-2348.
    PubMed     Text format     Abstract available


  50. O'LEARY JG, Demetris AJ, Philippe A, Freeman R, et al
    Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    Transplantation. 2017;101:2399-2409.
    PubMed     Text format     Abstract available


    September 2017
  51. WONG LL, Truong HP, Seto T, Lacar L, et al
    Marked decrease in urgent listing for liver transplantation over time: evolution of characteristics and outcomes of Status-1 liver transplantation.
    Transplantation. 2017 Sep 29. doi: 10.1097/TP.0000000000001967.
    PubMed     Text format     Abstract available


  52. CITRO A, Cantarelli E, Pellegrini S, Dugnani E, et al
    Antiinflammatory strategies in intrahepatic islet transplantation: a comparative study in preclinical models.
    Transplantation. 2017 Sep 8. doi: 10.1097/TP.0000000000001925.
    PubMed     Text format     Abstract available


  53. WEICHEN Z, Feibo L, Yufu Y, Yuanxing L, et al
    Isoglycyrrhizinate magnesium enhances hepatoprotective effect of FK506 on ischemia-reperfusion injury through HMGB1 inhibition in a rat model of liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001941.
    PubMed     Text format     Abstract available


  54. SNEIDERS D, Houwen T, Pengel LHM, Polak WG, et al
    Systematic review and meta-analysis of posttransplant hepatic artery and biliary complications in patients treated with transarterial chemoembolization before liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001936.
    PubMed     Text format     Abstract available


    August 2017
  55. CHARLTON M, Rinella M, Patel D, McCague K, et al
    Everolimus is Associated With Less Weight Gain Than Tacrolimus 2 Years Following Liver Transplantation: Results of a Randomized Multicenter Study.
    Transplantation. 2017 Aug 15. doi: 10.1097/TP.0000000000001913.
    PubMed     Text format     Abstract available


  56. DOSHI SD, Bittermann T, Schiano TD, Goldberg DS, et al
    Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure.
    Transplantation. 2017;101:1838-1844.
    PubMed     Text format     Abstract available


  57. ICHAI P, Laurent-Bellue A, Saliba F, Moreau D, et al
    Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.
    Transplantation. 2017;101:1830-1837.
    PubMed     Text format     Abstract available


  58. STINE JG, Intagliata N, Northup PG, Caldwell SH, et al
    Nonalcoholic Fatty Liver Disease, Portal Vein Thrombosis and Coagulation: More Questions Than Answers?
    Transplantation. 2017;101:e281-e282.
    PubMed     Text format    


    July 2017
  59. BOYLAN JM, Francois-Vaughan H, Gruppuso PA, Sanders JA, et al
    Engraftment and Repopulation Potential of Late Gestation Fetal Rat Hepatocytes.
    Transplantation. 2017 Jul 27. doi: 10.1097/TP.0000000000001882.
    PubMed     Text format     Abstract available


  60. LI Y, Ma D, Wang Z, Yang J, et al
    MicroRNA-155 Deficiency in Kupffer Cells Ameliorates Liver Ischemia-Reperfusion Injury in Mice.
    Transplantation. 2017;101:1600-1608.
    PubMed     Text format     Abstract available


  61. DUBROCK HM, Goldberg DS, Sussman NL, Bartolome SD, et al
    Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    Transplantation. 2017;101:1609-1615.
    PubMed     Text format     Abstract available


  62. JOCHMANS I, van Rosmalen M, Pirenne J, Samuel U, et al
    Adult Liver Allocation in Eurotransplant.
    Transplantation. 2017;101:1542-1550.
    PubMed     Text format     Abstract available


  63. DESCAMPS V, Brunet-Possenti F
    Human Herpesvirus 6 Reactivation in DRESS With Acute Liver Failure: A Missing Key Factor.
    Transplantation. 2017;101:e224-e225.
    PubMed     Text format    


    June 2017
  64. KIM PT, Klintmalm GB
    Authors' Reply: Does low Hepatic Artery Flow Increase Rate of Biliary Strictures in Deceased Donor Liver Transplantation?
    Transplantation. 2017 Jun 21. doi: 10.1097/TP.0000000000001855.
    PubMed     Text format    


  65. YI Z, Mayorga ME, Orman ES, Wheeler SB, et al
    Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Transplantation. 2017 Jun 20. doi: 10.1097/TP.0000000000001851.
    PubMed     Text format     Abstract available


    May 2017
  66. EMOND JC, Goodrich NP, Pomposelli JJ, Baker TB, et al
    Hepatic hemodynamics and portal flow modulation: The A2ALL experience.
    Transplantation. 2017 May 17. doi: 10.1097/TP.0000000000001823.
    PubMed     Text format     Abstract available


  67. KENSINGER CD, Feurer ID, Karp SJ
    An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer.
    Transplantation. 2017 May 4. doi: 10.1097/TP.0000000000001812.
    PubMed     Text format     Abstract available


  68. CHENG XS, Stedman MR, Chertow GM, Kim WR, et al
    Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation.
    Transplantation. 2017;101:1111-1119.
    PubMed     Text format     Abstract available


    March 2017
  69. MEHTA N, Heimbach J, Lee D, Dodge JL, et al
    Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001752.
    PubMed     Text format     Abstract available


  70. NEKRASOV V, Matsuoka L, Kaur N, Pita A, et al
    Improvement in the Outcomes of MELD >/= 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001738.
    PubMed     Text format     Abstract available


    February 2017
  71. PALUMBO T, Nakamura K, Lassman C, Kidani Y, et al
    Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.
    Transplantation. 2017;101:322-331.
    PubMed     Text format     Abstract available


  72. REDDY MS, Rajalingam R, Rela M
    Revisiting APOLT for Metabolic Liver Disease: A New Look at an Old Idea.
    Transplantation. 2017;101:260-266.
    PubMed     Text format     Abstract available


    January 2017
  73. SATAPATHY SK, Vanatta JM, Helmick R, Flowers A, et al
    Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Transplantation. 2017 Jan 17. doi: 10.1097/TP.0000000000001647.
    PubMed     Text format     Abstract available


  74. DEMARTINO ES, Cartin-Ceba R, Findlay JY, Heimbach JK, et al
    Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
    Transplantation. 2017;101:101-106.
    PubMed     Text format     Abstract available


    August 2016
  75. MOHKAM K, Fanget F, Darnis B, Harbaoui B, et al
    Use of systemic vasodilators for the management of Doppler ultrasound arterial abnormalities after orthotopic liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  76. DE CARLIS L, De Carlis R, Lauterio A, Di Sandro S, et al
    Sequential use of normothermic regional perfusion and hypothermic machine perfusion in donation after cardiac death liver transplantation with extended warm ischemia time.
    Transplantation. 2016.
    PubMed     Text format    


  77. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  78. CICALESE L, Shirafkan A, Jennings K, Zorzi D, et al
    Increased risk of death for patients on the waitlist for liver transplant residing at greater distance from specialized liver transplant centers in the USA.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  79. HART A, Schladt DP, Zeglin J, Pyke J, et al
    Predicting outcomes on the liver transplant waiting list in the United States: Accounting for large regional variation in organ availability and priority allocation points.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  80. MURALI AR, Chandra S, Stewart Z, Blazar BR, et al
    Graft versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    July 2016
  81. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  82. SIMKINS J, Abbo LM, Camargo JF, Rosa R, et al
    Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  83. SULLIVAN T, Weinberg A, Rana M, Patel G, et al
    The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  84. POMPOSELLI JJ, Goodrich NP, Emond JC, Humar A, et al
    Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Transplantation. 2016;100:1490-9.
    PubMed     Text format     Abstract available


    June 2016
  85. HSU CC, Chen CL, Wang CC, Lin CC, et al
    Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  86. WANG CW, Feng S, Covinsky KE, Hayssen H, et al
    A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  87. SALVALAGGIO PR, Seda Neto J, Alves JA, Fonseca EA, et al
    Consensus, Dilemmas, and Challenges in Living Donor Liver Transplantation in Latin America.
    Transplantation. 2016;100:1161-4.
    PubMed     Text format     Abstract available


    May 2016
  88. DEW MA, DiMartini AF, Ladner DP, Simpson MA, et al
    Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    March 2016
  89. CAO Y, Shahrestani S, Chew HC, Crawford M, et al
    Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  90. VANDEKERCKHOVE K, Coomans I, De Bruyne E, De Groote K, et al
    Evaluation of Exercise Performance, Cardiac Function, and Quality of Life in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: